In the United States, clinical testing is monitored by the federal and state governments, held to standards to ensure the safety and efficacy of these tests, as well as maintaining privacy for patients receiving a test. In order for the ABCTL to lawfully operate in the state of Arizona, it had to meet various legal criteria. These major legal considerations, in no particular order, are: Clinical Laboratory Improvement Amendments compliance; FDA Emergency Use Authorization (EUA); Health Insurance Portability and Accountability Act compliance; state licensure; patient, state, and federal result reporting; and liability. <br/>In this paper, the EUA pathway will be examined and contextualized in relation to the ABCTL. This will include an examination of the FDA regulations and policies that affect the laboratory during its operations, as well as a look at the different authorization pathways for diagnostic tests present during the COVID-19 pandemic.
For our project, we explored the growth of the ASU BioDesign Clinical Testing Laboratory (ABCTL) from a standard university research lab to a COVID-19 testing facility through a business lens. The lab has pioneered the saliva-test in the Western United States. This thesis analyzes the laboratory from various business concepts and aspects. The business agility of the lab and it’s quickness to innovation has allowed the lab to enjoy great success. Looking into the future, the laboratory has a promising future and will need to answer many questions to remain the premier COVID-19 testing institution in Arizona.
For our project, we explored the growth of the ASU BioDesign Clinical Testing Laboratory (ABCTL) from a standard university research lab to a COVID-19 testing facility through a business lens. The lab has pioneered the saliva-test in the Western United States. This thesis analyzes the laboratory from various business concepts and aspects. The business agility of the lab and it’s quickness to innovation has allowed the lab to enjoy great success. Looking into the future, the laboratory has a promising future and will need to answer many questions to remain the premier COVID-19 testing institution in Arizona.
The privatization of prisons within Arizona has been a hot button issue and needs to be further analyzed to determine their benefits and expenses. To begin this investigation into the effectiveness of private prisons within Arizona and possible steps that need to be taken for its rehabilitation certain definitions and prior research need to be understood. Following this explanation, areas such as costs analysis across different types of prisons, liability rates across differing types of prison guards, and the differing psychology of different types of prisons can be examined to gain an overall assessment of the current performance of privatized prisons within Arizona. After this in-depth analysis of the current private prison system within Arizona, the flaws of the system will become abundantly clear and the solutions that should be implemented to alleviate these problems will be discussed.
Change within the cannabis industry could lead to drastic improvements in social justice. Ever since marijuana was first regulated in the United States in the early 1900s, it has been used as the justification for the excessive incarceration and disenfranchisement of targeted groups, specifically, Black and Latino populations. Now, the growing popularity of marijuana, from both the recreational and entrepreneurial perspective, has led to the legalization of recreational cannabis in 15 states. <br/>Although this enterprise is highly profitable and alluring for consumers and business owners, the problem of underrepresentation of minority owned businesses within the industry still remains. This underrepresentation symbolizes the unjust ability for this enterprise to capitalize on those victimized by past drug regulations and on a larger scale, how it perpetuates institutionalized racism. The criminalization of marijuana not only allows for certain groups to remain successful in this booming billion-dollar operation, but also ensures that others remain unseen and left behind. <br/>This thesis aims to show the ways in which the legal cannabis industry can expand and encourage minority-owned businesses to venture into the sector. In this paper, I will attempt to outline the history of cannabis regulation and anti-drug campaigns, and illustrate the lack of diversity within the cannabis industry. I will also touch upon the remedies and reparations for racial inequality and how public policy can address entrepreneur’s demands in future policy considerations and industry practices.
For our project, we explored the growth of the ASU BioDesign Clinical Testing Laboratory (ABCTL) from a standard university research lab to a COVID-19 testing facility through a business lens. The lab has pioneered the saliva-test in the Western United States. This thesis analyzes the laboratory from various business concepts and aspects. The business agility of the lab and it’s quickness to innovation has allowed the lab to enjoy great success. Looking into the future, the laboratory has a promising future and will need to answer many questions to remain the premier COVID-19 testing institution in Arizona.
Early on in the pandemic, ASU leadership recognized an opportunity to involve the Biodesign Institute in an effort to keep local communities safe. Equipped with capital investments (and expertise) in diagnostic testing, university president Michael Crow tasked Dr. Joshua LaBaer - the executive director of Biodesign - to begin mapping out the lab’s logistic capabilities and operational plan. While initially testing through nasopharyngeal swabs, the Arizona Biodesign Clinical Testing Laboratory (ABCTL) eventually developed a saliva-based COVID-19 test that demonstrated higher efficacy and resource-efficiency. By maintaining rapid turnaround times for test results, the ABCTL has helped both the university population and local community operate safely. Lauded as a highly innovative testing site, the lab proved to be an essential asset as ASU, and the world, look to return to normalcy. The purpose of this thesis is to analyze the ABCTL’s inception and development using multi-faceted approaches from the business realm. There will be five topics discussed which are: • Volume I- Stakeholder Theory and Analysis Regarding the COVID-19 Bio-design Institute at Arizona State University (Claire Agee), • Volume II- The Lab as a Business Within a University Environment (Samuel Cosgrove) • Volume III- A Managerial Economic Perspective (Michael Qian) • Volume IV- An Analysis of its Upstream Supply Chain ( Kyle Mattson) • Volume V- An Operations Management Perspective (Corinne English) After these volumes, there will be a discussion about the growth and sustainability of the laboratory looking into the future. Although the ABCTL is young,the ever-changing market dynamics leave the organization with critical decisions going forward.
My personal experience with chronic illness served as inspiration for my thesis. At the age of five, I was diagnosed with severe asthma. The following year, I was hospitalized with pneumonia for nearly a month. Despite my health issues, I had a supportive family and grew up relatively well. During my freshman year of college, I hardly experienced any respiratory or allergy problems. Unfortunately, this time period was very short-lived. Due to rapid expansion, the natural flora and fauna of the desert has changed significantly within the last decade. Throughout the remainder of my undergraduate experience, I had a series of respiratory relapses that resulted in numerous medical withdrawals. In addition to health problems, I discovered the college environment poses unique challenges for students with chronic illnesses. Ultimately, this led me to delve deeper into this topic for my thesis.
commits. Outside of the house, there are people speeding, jaywalking, littering, sharing
medication, and driving without seat belts. Inside the house, people are downloading
music/movies, drinking while underage, using (and abusing) social media while under the age of
18, and reading another person’s mail. With so much of a focus on serious crimes, or felonies,
people tend to forget about the everyday actions in America that are also illegal. For example, a
police officer may not do anything if several cars are going well over the speed limit on the
highway, because it is normalized. This paper explores two sides of this issue: the psychological
side and the legal side. The goal is to find out how culpable people really are for their actions
when they do not have the mental intent that the they are determined to have in court. All human
behavior will be divided into two sections (people with non-extreme mental disorders and people
who have total control over their behavior). First, I dive into the complexity of anxiety,
depression, and ADHD, and explain how these disorders will subtly change someone’s behavior.
Next, I examine how actions like speeding and jaywalking and explain how certain illegal
actions have become so normalized that people may not be very guilty, even when they are
knowingly committing these crimes. I use different misdemeanors as examples for each of these
types of behaviors to argue why people should be more culpable (aggravating factors) or less
culpable (mitigating factors) because of their respective predispositions. Finally, I discuss issues
of fixing the criminal justice system such as: how to make all punishments fair/accurate, how to
fix the public’s distrust towards the law, and how to stop these normalized illegal behaviors for
all people, regardless of mental health or intent.